Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT0NUFM)

DTT Name Glucagon (GCG) DTT Info
Gene Name GCG

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
7 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
JNJ-64565111 DMVSUH1 Obesity 5B81 Phase 2 [1]
MEDI0382 DMSV60C Type-2 diabetes 5A11 Phase 2 [1]
MK-8521 DMVNAYE Type-2 diabetes 5A11 Phase 2 [1]
PB-1023 DMZCI04 Type-2 diabetes 5A11 Phase 2 [1]
PT320 DMZYKXN Parkinson disease 8A00.0 Phase 2 [2]
SAR425899 DM53IPE Diabetic complication 5A2Y Phase 1 [1]
ZP2929 DMRVDUM Type-1 diabetes 5A10 Phase 1 [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Clinical Trial Drug(s)
Molecule Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease. ACS Pharmacol Transl Sci. 2021 Mar 16;4(2):858-869.